| |
|
|
|
Oxford Global, Le Méridien Boston Cambridge 20 Sidney Street Cambridge Massachusetts, 02139
1st November - 2nd November
https://www.oxfordglobal.co.uk/discovery-us/agenda/download-agenda/
|
|
|
|
|
|
|
|
Organized by:
|
|
Oxford Global |
|
|
Invited Speakers:
|
|
| | | | | | | | | | | | | | | | | - MARK MURCKO | Director, Dewpoint Therapeutics
- DANE CORNEIL | Director of AI Science, BenevolentAI
- BETH HOFFMAN | Chief Executive Officer, Origami Therapeutics
- THOMAS NITTOLI | Senior Director, Regeneron Pharmaceuticals, Inc
- SHAHAR KEINAN | Chief Executive Officer, Polaris Quantum Biotech
- MATTHEW PHARRIS | Senior Scientist, UCB
- JOHN SANTA MARIA | Associate Director, Fog Pharmaceuticals
- ERIC MIELE | Associate Director, AstraZeneca
- SHAUN MCLOUGHLIN | Principal Research Scientist, AbbVie
- ISTVAN ENYEDY | Senior Director, Theseus Pharmaceuticals
- JONATHAN PROTO | Principal Scientist, Sanofi
- LAUREN GOODRICH | Vice President, Therapeutic Discovery, Nimble Therapeutics
- HASAN KHAN | Senior Scientist, AbbVie
- JEFF MESSER | Director, GSK
- EMMANUEL BENGIO | Senior Machine Learning Scientist, Recursion Pharmaceuticals
- YUXIN LIANG | Principal Scientific Manager, Genentech
- JAMES HICKMAN | Professor, Nanoscience Technology Center, University of Central Florida
- ERIC MARTIN | Director, Computational Chemistry, Novartis
- CHRIS TAME | Director, Benevolent AI
- XIANG CHEN | Associate Member, St Jude Children’s Research Hospital
- PETRINA KAMYA | Head of AI Platform, Insilico Medicine
- YUAN WANG | Head, Research Analytics, UCB
- NILS JAKOB HANSEN | Chief Executive Officer, Vipergen ApS
- MAXIMILIAN SCHUIER | Senior Global Medical Affairs Leader Neuropsychiatry, Janssen
- BRADLEY MORGAN | Senior Vice President, Cytokinetics
- STEFAN PEUKERT | Associate Director, Novartis
- MIKE SCHOPPERLE | Chief Executive Officer, CureMeta
- PAUL SCOLA | Group Director, Bristol Myers Squibb
- CHRISTOPHER BARBIERI | Associate Director, Bristol Myers Squibb
- MARTIN REDHEAD | Executive Director Primary Pharmacology, Exscientia
- TIM AHFELDT | Vice President of Advanced Translational Modelling, Recursion Pharmaceuticals
- ANGEL GUZMAN-PEREZ | Head of Chemistry, Scorpion Therapeutics
- JEANNIE LEE | Professor of Genetics, Harvard Medical School
- ELLIOTT NICKBARG | Principal Scientist, Merck
- JOHN QUINN | Distinguished Scientist and Head of SPR-Biophysics, Genentech
- RALPH MAZITSCHEK | Investigator, Harvard Medical School
- THOMAS HARTUNG | Professor and Chair, John Hopkins University
- HONGWU WANG | Principal Scientist, Merck & Co., Inc
- SURESH KUMAR | Vice President R&D, Progenra
- AARON FRANK | Director and Head of Computational Chemistry, Arrakis Therapeutics
- SINA MOHAMMADI | Principal Scientist, Merck
- TOMEK CIERPICKI | Professor, University of Michigan
- DAVE MAUGER | Director of Data Science, Arrakis Therapeutics
- TOBIAS RAABE | Research Assistant Professor, University of Pennsylvania
- ABHINAV SHARMA | Senior Scientist, AbbVie
- ESTHER LEE | Associate Director, AstraZeneca
- KEVIN ROBBINS | Associate Principal Scientist, AstraZeneca
- RAJESWARI BASU | Research Scientist, Boehringer Ingelheim
- BANU PRIYA SRIDHARAN | Associate Director, GSK
- JOE FRANKLIN | Senior Vice President, Anagenex
- GISELE NISHIGUCHI | Group Leader, St Jude Children’s Hospital
- RUBEN ABAGYAN | Professor, University of California
- INDIA OTT | Research Scientist, AstraZeneca
- LUCAS MASTROMATTEO | Data Analyst, GSK
|
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
1st November
|
|
|
|
|
|
|
|
Registration:
|
|
https://www.oxfordglobal.co.uk/discovery-us/book-now/
|
|
|
E-mail:
|
|
m.blakey@oxfordglobal.com
|
|
|
|
|
|
|
|
|